Multidistrict Litigation (MDL): How Large U.S. Claim Groups Are Managed

Multidistrict litigation is a federal procedural mechanism that consolidates civil cases sharing common factual questions from multiple U.S. district courts into a single transferee court for coordinated pretrial proceedings. The system was created by Congress in 1968 under 28 U.S.C. § 1407 to prevent duplicative discovery, inconsistent rulings, and the enormous judicial waste that arises when thousands of plaintiffs file identical or near-identical claims in separate courts. Understanding MDL mechanics is essential for anyone tracking large-scale product liability, pharmaceutical, or mass tort claims — categories that now account for a substantial portion of the entire federal civil docket.



Definition and scope

Multidistrict litigation is authorized exclusively by 28 U.S.C. § 1407, which grants the Judicial Panel on Multidistrict Litigation (JPML) authority to transfer civil actions pending in different federal districts to a single district for coordinated or consolidated pretrial proceedings when those actions involve "one or more common questions of fact." The statute applies only to federal civil cases — state court cases are not subject to JPML transfer orders, though state courts have parallel consolidation mechanisms.

The scope of MDL is substantial. As of the JPML's published docket statistics, MDL proceedings at various points have represented over 50 percent of the entire federal civil caseload (Judicial Panel on Multidistrict Litigation, 2022 Annual Report). A single MDL can encompass tens of thousands of individual plaintiffs — the opioid MDL (MDL No. 2804, In re: National Prescription Opiate Litigation) consolidated more than 3,000 cases in the Northern District of Ohio.

MDL is distinct from a class action in a critical structural sense: each plaintiff in an MDL retains an individual claim. There is no class certification requirement, no Rule 23 analysis, and no opt-out mechanism tied to class membership. MDL is a pretrial coordination tool, not a merits-aggregation device.

The JPML itself is composed of 7 federal judges designated by the Chief Justice of the United States under 28 U.S.C. § 1407(d). It does not try cases; it only decides whether transfer is appropriate and to which district.


Core mechanics or structure

Initiation. Any party — plaintiff, defendant, or potential tag-along party — may file a motion to transfer with the JPML. The Panel also has authority to initiate proceedings on its own. A motion must identify the actions to be transferred, explain the common factual questions, and propose a transferee district.

Briefing and hearing. After a motion is filed, opposing parties have an opportunity to respond. The JPML schedules oral argument at periodic hearing sessions held in rotating federal courthouses. The Panel publishes its schedule and hearing orders through its official docket at jpml.uscourts.gov.

Transfer order. If the JPML finds that transfer will serve "the convenience of parties and witnesses and will promote the just and efficient conduct of such actions" (28 U.S.C. § 1407(a)), it issues a transfer order designating a transferee judge. That judge then manages all pretrial proceedings for every transferred case.

Tag-along cases. Cases filed after the initial transfer order that share the same common factual questions are designated "tag-along actions." Counsel may file a notice of tag-along action with the JPML, which then issues a conditional transfer order (CTO). Parties can oppose a CTO within the time limit set by JPML Rules.

Pretrial proceedings. The transferee judge has broad authority to manage discovery — including coordinating depositions, handling document production, resolving privilege disputes, and ruling on dispositive motions such as summary judgment. The judge typically appoints Plaintiffs' Steering Committees (PSC) and Liaison Counsel to manage the plaintiff side efficiently.

Bellwether trials. Most large MDLs use bellwether trials — a subset of representative cases selected and tried to verdict — to generate data on likely jury outcomes. These results pressure global settlement negotiations without resolving all individual cases.

Remand. Under § 1407, once pretrial proceedings conclude, each case must be remanded to its original transferee district for trial — unless the parties consent to trial before the MDL judge or the case settles within the MDL. In practice, the overwhelming majority of MDL cases resolve through settlement rather than remand and trial.

For a broader view of how individual claims enter federal court, see Federal Court Jurisdiction and the Legal Claims Process Overview.


Causal relationships or drivers

MDL formation is driven by a specific pattern of litigation: a single product, drug, device, or practice that injures large numbers of people who then file in courts across the country. The primary drivers are:

Pharmaceutical and device mass torts. Drug recalls, defective implants, and contaminated products reliably generate MDLs because injuries are geographically dispersed but causally identical. MDL No. 2327 (In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation) consolidated over 100,000 cases in the Southern District of West Virginia — the largest MDL by case count in U.S. history as of the JPML's published records.

Duplicative discovery burden. Without MDL, every plaintiff's attorney would independently depose the same corporate witnesses, request the same internal documents, and litigate the same expert witness challenges (Daubert motions). The efficiency loss is enormous and falls on both parties and the federal judiciary.

Forum shopping pressure. Before § 1407 existed, defendants faced inconsistent pretrial rulings on identical legal and factual questions depending on where each case was filed. MDL creates a single authoritative set of pretrial rulings, reducing the incentive to file in favorable jurisdictions. The relationship between jurisdiction and venue is a core structural driver of MDL formation.

Global settlement leverage. Defendants in high-volume litigation often prefer a single negotiating forum where a global resolution is administratively possible. MDL creates that forum by consolidating claims under one judge with authority over all pretrial proceedings.


Classification boundaries

MDL is not a monolithic procedure — the label covers distinct structural configurations.

Federal MDL (28 U.S.C. § 1407). The standard JPML transfer process described above. Applies only to federal civil cases.

State court coordinated proceedings. California's Judicial Council Coordination Proceedings (JCCP), for example, operate under California Code of Civil Procedure § 404 and allow consolidation of state-filed cases in a single California superior court. These are not MDLs — they run in parallel and may address overlapping plaintiff populations. Texas, New Jersey, and other states have equivalent mechanisms.

Multidistrict litigation vs. class action. Under Federal Rule of Civil Procedure 23, a class action requires certification of a defined class, commonality, typicality, and adequacy of representation. MDL requires none of these — the cases are coordinated, not merged. Plaintiffs in an MDL are not class members; they are individual litigants whose pretrial proceedings are handled together. This distinction is developed further at Class Action Claims and Mass Tort Claims.

Consolidated actions vs. tag-along actions. Actions included in the original transfer order are "consolidated" for MDL purposes. Later-filed actions that qualify are "tag-along" actions subject to conditional transfer orders. The legal treatment is functionally identical after transfer.


Tradeoffs and tensions

Plaintiff autonomy vs. efficiency. MDL imposes significant coordination overhead on individual plaintiffs. Plaintiffs' Steering Committee decisions bind all plaintiffs in certain procedural respects, even though individual plaintiffs never voted for PSC counsel. Critics — including the American College of Trial Lawyers in published position papers — have argued this creates accountability gaps when PSC counsel negotiate global settlements that individual claimants may not understand or accept.

Bellwether selection bias. The outcome of bellwether trials only approximates the distribution of outcomes across all claims if the selection process is genuinely representative. When selection is adversarial, both sides may choose cases favorable to their theory, distorting the settlement valuation signal.

Remand in name only. Section 1407 requires remand for trial, but the JPML and courts have interpreted § 1404 (general venue transfer) to allow transferee judges to retain cases for trial with party consent. This "self-transfer" practice — sometimes called the Lexecon problem after Lexecon Inc. v. Milberg Weiss, 523 U.S. 26 (1998) — was curtailed by the Supreme Court, which held that MDL transferee courts cannot use § 1404 to transfer cases to themselves for trial. Congress has periodically debated amending § 1407 to permit trial authority in MDL courts, but no amendment had passed as of the 110th Congress.

Settlement allocation opacity. Global MDL settlements often distribute funds through Claims Administrators using point systems or grid-based allocation formulas that are not publicly disclosed in detail. Individual plaintiffs may receive allocations with limited ability to challenge the methodology. The damages types framework that governs individual recovery can be compressed or modified within aggregate settlement structures.


Common misconceptions

Misconception: MDL means a class action. Incorrect. MDL and class action are separate procedural devices. A class action under Rule 23 requires certification, binds absent class members, and can proceed to a class-wide trial or judgment. MDL consolidates individual cases for pretrial purposes only. No class is certified; no plaintiff is bound to another plaintiff's verdict.

Misconception: Joining an MDL eliminates the statute of limitations clock. Incorrect. Filing a case in federal court and having it transferred to an MDL tolls nothing by itself. Each plaintiff must independently file a timely complaint before the applicable statute of limitations expires. The MDL transfer order does not extend filing deadlines.

Misconception: The MDL judge decides individual cases. Incorrect. The transferee judge manages pretrial proceedings — discovery, expert challenges, motions to dismiss, summary judgment. Trial authority over individual cases, absent consent, belongs to the originating district under § 1407(a).

Misconception: All MDL cases settle. Statistically, the vast majority do — but settlement is not guaranteed. Some MDLs terminate with global settlements; others end with remand waves, individual verdicts, or defendants prevailing on dispositive motions. The settlement vs. trial decision remains individual for each plaintiff even within an MDL.

Misconception: MDL plaintiffs share damages equally. Incorrect. Each plaintiff's recovery is determined by that plaintiff's individual damages, injury severity, and the specific facts of that case. Allocation grids in global settlements assign different point values to different injury categories. Equal sharing is neither required nor common.


Checklist or steps (non-advisory)

The following is a factual sequence describing the procedural phases of federal MDL formation and progression. This is a reference description, not procedural guidance.

Phase 1 — Transfer petition
- [ ] Motion to transfer filed with the JPML by any party (or initiated sua sponte)
- [ ] Motion identifies cases pending in 2 or more federal districts with common factual questions
- [ ] Proposed transferee district identified
- [ ] Supporting brief filed identifying efficiency and convenience rationale under § 1407(a)

Phase 2 — JPML review
- [ ] JPML dockets the motion and notifies all parties in all identified actions
- [ ] Response briefs filed by opposing parties within JPML-set deadlines
- [ ] JPML schedules oral argument at a designated hearing session
- [ ] Panel issues transfer order or denial

Phase 3 — MDL establishment
- [ ] Transferee judge assigned; MDL docket number assigned by JPML
- [ ] Initial case management conference scheduled by transferee judge
- [ ] Plaintiffs' Steering Committee and Liaison Counsel appointed
- [ ] Master complaint and master answer (if any) filed
- [ ] Discovery schedule and Lone Pine order (if applicable) entered

Phase 4 — Pretrial proceedings
- [ ] Coordinated document production and depositions conducted
- [ ] Expert witnesses designated; Daubert motions litigated under Federal Rules of Evidence
- [ ] Bellwether cases selected, briefed, and tried
- [ ] Summary judgment motions resolved for bellwether cases

Phase 5 — Resolution
- [ ] Global settlement negotiated (if applicable) and Claims Administrator appointed
- [ ] Individual settlement opt-in or opt-out procedures administered
- [ ] Cases not settling remanded to originating districts via JPML remand order
- [ ] MDL docket administratively closed after resolution of all pending actions


Reference table or matrix

Feature Federal MDL (§ 1407) Class Action (Rule 23) State Court Consolidation (e.g., JCCP)
Governing authority 28 U.S.C. § 1407; JPML Rules Fed. R. Civ. P. 23 State procedural codes (e.g., Cal. CCP § 404)
Certification required? No Yes (Rule 23(a) and (b)) Varies by state
Individual claims retained? Yes No (class members bound) Yes
Scope Federal civil cases only Federal and state State cases only
Trial authority Originating district (absent consent) Certifying court Coordinating court
Settlement binding effect Per individual agreement Binds class (after court approval) Per individual agreement
Governing body JPML (7 judges) Certifying judge State judicial council or court
Opt-out mechanism Not applicable Yes (Rule 23(b)(3) classes) Varies
Common examples Opioid litigation, pelvic mesh, talc Data breach settlements, consumer fraud California pharmaceutical cases

Major MDL Designations by Case Volume (Selected Historical Examples)

MDL No. Name District Approximate Case Count (at peak) Primary Claim Type
2327 Ethicon Pelvic Repair S.D. W. Va. 100,000+ Product liability
2804 National Prescription Opiate N.D. Ohio 3,000+ Mass tort / public nuisance
2885 3M Combat Arms Earplugs N.D. Fla. 230,000+ Product liability
2738 Johnson's Baby Powder (Talc) D.N.J. 38,000+ Product liability
2179 Deepwater Horizon E.D. La. 100,000+ Environmental / tort

Case counts derived from JPML published statistics and federal court public dockets; figures reflect peak pretrial enrollment and are subject to change as cases resolve.


References

📜 4 regulatory citations referenced  ·  🔍 Monitored by ANA Regulatory Watch  ·  View update log

Explore This Site